- Home
- FOLD vs RDN Comparison
FOLD vs RDN Comparison
Compare FOLD & RDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FOLD | RDN |
|---|---|---|
| Founded | 2002 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.5B |
| IPO Year | 2006 | 2008 |
Fundamental Metrics
Financial Performance| Metric | FOLD | RDN |
|---|---|---|
| Price | $14.49 | $35.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | $27.25 | ★ $40.67 |
| AVG Volume (30 Days) | ★ 2.4M | 900.4K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.73% |
| EPS Growth | ★ 50.00 | 5.61 |
| EPS | N/A | ★ 4.14 |
| Revenue | N/A | ★ $1,197,084,000.00 |
| Revenue This Year | $20.50 | N/A |
| Revenue Next Year | $18.59 | $2.66 |
| P/E Ratio | ★ N/A | $8.56 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.66 | $31.50 |
| 52 Week High | $14.50 | $38.84 |
Technical Indicators
Market Signals| Indicator | FOLD | RDN |
|---|---|---|
| Relative Strength Index (RSI) | 74.18 | 55.09 |
| Support Level | $14.21 | $34.20 |
| Resistance Level | N/A | $36.00 |
| Average True Range (ATR) | 0.02 | 0.74 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 100.00 | 40.48 |
Price Performance
Historical ComparisonAbout FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About RDN Radian Group Inc.
Radian Group Inc is engaged in mortgage and real estate services. It provides both credit-related mortgage insurance coverage and other products and services across the residential real estate and mortgage finance industries. It has one business segment Mortgage Insurance. The Mortgage Insurance segment aggregates, manages, and distributes U.S. mortgage credit risk for the benefit of mortgage lending institutions and mortgage credit investors, through private mortgage insurance on residential first-lien mortgage loans, and also offers other credit risk management solutions, including contract underwriting, to customers. It also provides other mortgage and real estate products and services through Mortgage Conduit, Title, Real Estate Services, and Real Estate Technology businesses.